News & Events
News, industry insights and noteworthy events.
At Tanner, we take pride in the success of our partnerships and acknowledge the milestones achieved in pursuing our mission; to improve lives by increasing access to medicines around the world.
For media or press inquiries, please email us.
Contact UsAll Articles
-
The impact of climate change on the pharma supply chain
Climate change has the potential to cause major disruptions to the global pharma supply chain and tragic health impacts for the global population. Many in the pharma industry are making efforts to reduce emissions and implement more eco-friendly processes to ensure patients can continue to access their medicines efficiently and sustainably. Pharmaceutical supply chains are…
Read More -
The Mexico Pharma Market: Growth factors and advantages for manufacturing
Global pharma companies are turning their focus to Mexico, with its low manufacturing costs and proximity to the US as two of the major advantages. We take a look at some of the factors behind the growth of the Mexican pharma market, and the challenges with meeting regulatory requirements. Mexico is Latin America’s second-largest pharmaceutical market…
Read More -
The Brazilian Pharma Market: Key information and what may change
Brazil has the largest pharmaceutical market in Latin America, and recent political changes have raised speculation about what other changes could be in store. We take a look at the country’s pharma market and explore what could be around the corner in terms of legislation. Brazil is the largest country in Latin America, with a…
Read More -
Managing drug shortages: Getting medicines to patients in need
Patients around the world are experiencing drug shortages, with production still recovering from the disruption caused by Covid-19, the war in Ukraine, and rising energy costs. Tanner Pharma is tackling these issues head-on, managing disruptions and ensuring that a range of treatments reach patients wherever they are. Ongoing drug shortages are not a new occurrence,…
Read More -
Enabling access continuity of medical treatments for patients
There are different instances where patients may experience interruptions in treatment access, entirely lose access they once had, or completely lack access to a commercialized medicine that just isn’t available where they live. The common denominator being that all factors are almost always beyond the patient’s control. Finding ways to mitigate and overcome these challenges…
Read More -
Overcoming challenges with medical product classification in Latin America
Classification of medical products can vary greatly from one country to another, especially in Latin America. To sell products in specific markets, product owners must understand where any differences lie in how they are categorized. Learn more about navigating these market complexities. Medical product expansion in emerging markets such as Latin America can be a…
Read More -
The pharma companies working towards supply chain sustainability
The pharma supply chain is taking great efforts to reduce its carbon footprint and improve long-term sustainability. We take a look at some of the measures deployed to reduce the carbon footprint in the supply of PPE and lateral flow tests. Like most sectors, the pharmaceutical industry of the past has contributed to greenhouse gas…
Read More -
Tanner Pharma Plants 9,175 Trees in the UK in Partnership with Treeapp
Tanner x Treeapp Tanner and Treeapp have been working together since February 2022. In that time we have planted 9,175 trees together in the UK, at the Treeapp site in Llangoedmor in West Wales (more info here). Prior to intervention, this land was degraded forest. 16 different species were planted here, the most prominent being…
Read More -
Overcoming procurement and supply chain challenges in clinical trials
The global pandemic has had a significant impact on clinical trials, forcing operators to alter their processes. Tanner Pharma’s Clinical Trial Solutions (TannerCTS) division has been working to overcome challenges with procurement and ensure supply continuity, while looking to the future by embracing technological innovations. Discover more from Georg Schulz, Executive Vice President of Clinical…
Read More -
Hispanic Heritage Month 2022
Hispanic Heritage Month runs from September 15 – October 15 and recognizes the cultures, histories, achievements and contributions of Hispanic Americans. Unlike many monthly observances, Hispanic Heritage Month begins in the middle rather than the start of September. This is because it coincides with the national independence days of several Latin American countries including Costa Rica,…
Read More -
Building a global supply chain network for clinical trial products
On-time deliveries are paramount in the pharmaceutical world. But ensuring expedited transfer from one location to another is only a piece of the process. Packaging requirements, temperature controls, country-specific transport and storage capabilities, and more must be strictly managed to ensure success. Tanner Pharma Group has established a specialist storage and distribution network with a…
Read More -
Protection through preparation: How self-test kits became essential
The value of self-test kits has surged in the last two years and these items are now viewed as an integral part of the fight against a rise of infectious diseases, from Covid-19 to monkeypox. Learn more about how Tanner’s GMS division ensures sufficient supply as demand increases. Self-test kits have grown in importance since…
Read More -
Life-Long Friends Share a Passion for Improving Lives | Steve Scalia
In 1984, a cross-country, family move brought Steve Scalia from the West Coast to North Carolina. On his first day at a new middle school, he met another quite adventurous young man by the name of Banks Bourne, and the two became fast friends. Unbeknownst to them, amid their far-fetched, childhood aspirations, the two were…
Read More -
Tanner Pharma Group Supports Ukraine
In response to the ongoing crisis in Ukraine, Tanner Pharma Group will contribute over $124,500 and donate 14,803 units of essential products to select organizations that are making a positive impact and actively providing direct aid and relief to those most affected by Russia’s war in Ukraine. Learn more about the work of these organizations…
Read More -
Tanner Pharma is a Finalist in the Supply Chain Excellence Awards 2022
Tanner Pharma Group will be considered in two categories as part of the the Supply Chain Excellence Awards 2022 alongside partners Akeso & Company and Kuehne+Nagel for their collaborative efforts supporting immediate COVID response. Learn more about these two categories below: The Healthcare & Pharmaceutical Supply Chain Excellence Award – Private Sector This award looks to recognize techniques, projects…
Read More -
Q&A with LATAM Medtech Leaders
In this interview, Steve Scalia, president of Tanner Pharma Group, speaks with Julio Martinez-Clark, founder and producer of the LATAM MedTech Leaders podcast series and CEO of Bioaccess, about Tanner’s experience in the LATAM pharmaceutical market. He also shares his insights on market challenges and trends, and how Tanner is bridging the gap in patient…
Read More -
Ascentage Pharma and Tanner Pharma Group Initiate a Global Innovative Named Patient Program
SUZHOU, China and ROCKVILLE, Md. and CHARLOTTE, N.C./PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, and Tanner Pharma Group (“Tanner Pharma”), a global pharmaceutical services provider of specialty access solutions, have jointly launched an innovative Named Patient Program (NPP) for olverembatinib. This collaboration will allow access to Ascentage Pharma’s novel…
Read More -
Increasing the Efficiency of Clinical Trials
In this interview, Georg Schulz, EVP of Clinical Services & Senior Director of Corporate Development at Tanner Pharma Group speaks with The Medicine Maker about increasing the efficiency of clinical trials. He also offers his perspective on the trends and challenges affecting clinical trials, including the growing prevalence of digital and decentralized trials and COVID-19…
Read More